Do you recommend prophylactic cranial irradiation for ES-SCLC patients now that immunotherapy is included in the treatment schema?
If so, do you allow a period of "washout" between immunotherapy and radiation?
Answer from: Medical Oncologist at Academic Institution
I do not pursue PCI for most patients with extensive stage SCLC. We know the EORTC phase III study led by Ben Slotman (NEJM 2007) showed a decrease in the cumulative risk of brain metastases that translated into a survival benefit. One of the flaws of the study was the lack of baselin...
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
I became much less enthusiastic about recommending PCI in such patients. Would still bring it up for discussion in younger patients with excellent performance status and "oligometastatic" extensive stage, and would be willing to deliver it if patients were interested.